BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35394803)

  • 21. Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers.
    Beijer LJ; Rietveld AC; Ruiter MB; Geurts AC
    Clin Linguist Phon; 2014 Dec; 28(12):927-50. PubMed ID: 25025268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vowel acoustics in Parkinson's disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions.
    Tjaden K; Lam J; Wilding G
    J Speech Lang Hear Res; 2013 Oct; 56(5):1485-502. PubMed ID: 23838989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perceptual measures of speech from individuals with Parkinson's disease and multiple sclerosis: intelligibility and beyond.
    Sussman JE; Tjaden K
    J Speech Lang Hear Res; 2012 Aug; 55(4):1208-19. PubMed ID: 22232396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of clear, loud, and slow speech on scaled intelligibility and speech severity in Parkinson's disease and multiple sclerosis.
    Tjaden K; Sussman JE; Wilding GE
    J Speech Lang Hear Res; 2014 Jun; 57(3):779-92. PubMed ID: 24687042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative acoustic metrics of vowel production in mandarin-speakers with post-stroke spastic dysarthria.
    Ge S; Wan Q; Yin M; Wang Y; Huang Z
    Clin Linguist Phon; 2021 Aug; 35(8):779-792. PubMed ID: 32985269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intelligibility Across a Reading Passage: The Effect of Dysarthria and Cued Speaking Styles.
    van Brenk F; Stipancic K; Kain A; Tjaden K
    Am J Speech Lang Pathol; 2022 Jan; 31(1):390-408. PubMed ID: 34982941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between acoustic measures and speech naturalness ratings in Parkinson's disease: A within-speaker approach.
    Klopfenstein M
    Clin Linguist Phon; 2015; 29(12):938-54. PubMed ID: 26403503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
    K-Y Ma J; Schneider CB; Hoffmann R; Storch A
    J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Parkinsonian dysarthria].
    Gentil M; Pollak P; Perret J
    Rev Neurol (Paris); 1995 Feb; 151(2):105-12. PubMed ID: 7676137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prosodic Improvement in Persons with Parkinson Disease Receiving SPEAK OUT!® Voice Therapy.
    Boutsen F; Park E; Dvorak J; Cid C
    Folia Phoniatr Logop; 2018; 70(2):51-58. PubMed ID: 29996139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Clear Speech on the Perceptual and Acoustic Properties of Fricative-Vowel Sequences in Speakers With Dysarthria.
    Martel-Sauvageau V; Breton M; Chabot A; Langlois M
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1410-1428. PubMed ID: 33784184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acoustic and Perceptual Consequences of Speech Cues for Children With Dysarthria.
    Levy ES; Chang YM; Ancelle JA; McAuliffe MJ
    J Speech Lang Hear Res; 2017 Jun; 60(6S):1766-1779. PubMed ID: 28655046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Intelligibility Gains in Individuals With Dysarthria From Baseline Speech Features.
    Fletcher AR; McAuliffe MJ; Lansford KL; Sinex DG; Liss JM
    J Speech Lang Hear Res; 2017 Nov; 60(11):3043-3057. PubMed ID: 29075753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intensive speech treatment on Mandarin speakers with Parkinson's Disease: A review.
    Chen Q; Chen B; Wan Q; Wang Y; Li J; Huang Z
    Medicine (Baltimore); 2023 Feb; 102(6):e32900. PubMed ID: 36820601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ¿Notas La Diferencia? [Do You Hear the Difference?]: Perceptual Consequences of Intensive Voice Treatment in Spanish Speakers With Parkinson's Disease.
    Moya-Galé G; Hernández JD; Goudarzi A; Walsh SJ
    J Speech Lang Hear Res; 2024 Mar; ():1-21. PubMed ID: 38513128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acoustic and perceptual correlates of faster-than-habitual speech produced by speakers with Parkinson's disease and multiple sclerosis.
    Kuo C; Tjaden K; Sussman JE
    J Commun Disord; 2014; 52():156-69. PubMed ID: 25287378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated Vowel Articulation Analysis in Connected Speech Among Progressive Neurological Diseases, Dysarthria Types, and Dysarthria Severities.
    Illner V; Tykalova T; Skrabal D; Klempir J; Rusz J
    J Speech Lang Hear Res; 2023 Aug; 66(8):2600-2621. PubMed ID: 37499137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders.
    Weismer G; Jeng JY; Laures JS; Kent RD; Kent JF
    Folia Phoniatr Logop; 2001; 53(1):1-18. PubMed ID: 11125256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of rate reduction and increased loudness on fundamental frequency characteristics in dysarthria.
    Tjaden K; Wilding G
    Folia Phoniatr Logop; 2011; 63(4):178-86. PubMed ID: 20938199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of SPEAK OUT! & LOUD Crowd on Functional Speech Measures in Parkinson's Disease.
    Sullivan L; Martin E; Allison KM
    Am J Speech Lang Pathol; 2024 Jul; 33(4):1930-1951. PubMed ID: 38838243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.